RYTELO Trademark

Trademark Overview

On Tuesday, April 20, 2021, a trademark application was filed for RYTELO with the United States Patent and Trademark Office. The USPTO has given the RYTELO trademark a serial number of 90658752. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, February 6, 2024. This trademark is owned by Geron Corporation. The RYTELO trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals for the treatment, diagnosis or prophylaxis of human diseases, disorders and conditions, namely, cancer, and diseases, disorders and conditions of the hematological systems
rytelo

General Information

Serial Number90658752
Word MarkRYTELO
Filing DateTuesday, April 20, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, February 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 19, 2022

Trademark Statements

Goods and Servicespharmaceuticals for the treatment, diagnosis or prophylaxis of human diseases, disorders and conditions, namely, cancer, and diseases, disorders and conditions of the hematological systems

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 28, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGeron Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFoster City, CA 94404
Party NameGeron Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFoster City, CA 94404

Trademark Events

Event DateEvent Description
Monday, December 13, 2021NON-FINAL ACTION E-MAILED
Friday, April 23, 2021NEW APPLICATION ENTERED
Wednesday, July 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 13, 2021ASSIGNED TO EXAMINER
Monday, December 13, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 13, 2021NON-FINAL ACTION WRITTEN
Friday, June 10, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 10, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 10, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 29, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 19, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 15, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 15, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 7, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, March 7, 2023SOU EXTENSION 1 FILED
Tuesday, March 7, 2023SOU EXTENSION 1 GRANTED
Thursday, March 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 8, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 8, 2023SOU EXTENSION 2 FILED
Tuesday, August 8, 2023SOU EXTENSION 2 GRANTED
Thursday, August 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 6, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 6, 2024SOU EXTENSION 3 FILED
Tuesday, February 6, 2024SOU EXTENSION 3 GRANTED
Thursday, February 8, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 9, 2024TEAS STATEMENT OF USE RECEIVED
Friday, September 13, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

rytelo conditions disorders diseases cancer hematological systems namely treatment human pharmaceuticals